Are you, or someone you know, a carrier of the FMR1 premutation?
If so, you may be eligible for our study of language and social characteristics in fragile X syndrome and the FMR1 premutation!
Our research team at Northwestern University is studying language and social characteristics related to the FMR1 gene involved in fragile X syndrome (FXS). We have been fortunate enough to work with many wonderful families in the fragile X community, and have promising results on the horizon! A big THANK YOU to everyone we have had the opportunity to work with so far! Similar to the mission of the National Fragile X Foundation, we are seeking to accelerate the process of learning more about FXS by advancing research toward improving treatments for this specific population. In order to achieve this goal, we are looking to recruit additional families affected by FXS, and women who carry the FMR1 premutation and who grew up in Iowa.
Why Iowa?
Standardized academic testing (for example, the Iowa Test of Basic Skills (ITBS)) refers to state or district-administered tests, given to most students during elementary, middle, and high school. These tests are often administered multiple times throughout childhood and adolescence, and so provide valuable data on language and cognitive development over time. Studying these standardized test scores allows us to see how parents’ abilities may relate to variation in the FMR1 gene.
Criteria
We are recruiting individuals who:
- Attended elementary, middle, or high school in Iowa
AND - Are carriers of the FMR1 premutation or the parent of a child with Fragile X syndrome.
Where is the study?
- We are located in Evanston, IL (just outside Chicago).
- We can travel to you or pay for your travel to us, whichever is most convenient for you and your family.
What will I receive?
- Each family member who participates will receive up to $50 compensation, depending on level of participation.
- Upon request, we can provide the results of genetic testing and completed research assessments.
What does the study involve?
- Participation can range from questionnaires only, to a full participation in an on-person battery of assessments that will last approximately 4 hours. The full battery includes tasks such as solving puzzles, telling stories, and talking about your friendships.
- A blood draw (optional).
- If your child with FXS participates in the study, you will be asked to complete an additional in-person or phone interview about your child’s developmental history that lasts approximately 3 hours.
Contact
- Please email us at familystudy@northwestern.edu or call us at 1-877-275-7187 for more information!
- You can also visit us at http://familystudy.northwestern.edu for more information about our study.
Thank you in advance for your help and support of this important research!
Sincerely,
The Neurodevelopmental Disabilities Lab
Northwestern University
877-275-7187
familystudy@northwestern.edu
IRB STUDY #STU00051863
PI: Dr. Molly Losh
Dept: Communication Sciences and Disorders
Our Most Recent Opportunities
Study: Autonomic and Sensory Functioning in Infants with FMR1 Conditions
Dr. Jane Roberts and the research staff at the Neurodevelopmental Disorders Laboratory at USC are conducting a research study to learn about the development of infants with Fragile X syndrome and Fragile X premutation over the first few years of life.
Survey: Research Experiences in Fragile X Families
The Brain and Biomarker Lab at the University of Oklahoma is conducting a survey to learn about experiences with research, particularly biomedical research, in families with Fragile X syndrome (FXS).
Study: Language Study for Children and Adolescents with Fragile X syndrome
Researchers at the University of Wisconsin-Madison and the University of Massachusetts-Amherst are conducting a study to learn about links between learning and language in Fragile X syndrome.
Survey: Fragile X Nutrition Survey
The University of Wisconsin-Madison is conducting a survey to learn about associations between infant feeding and neurodevelopment in children with Fragile X syndrome.
Clinical Trial: Phase 2B/3 Studies of BPN14770 in Fragile X syndrome
Tetra Therapeutics is conducting a two randomized, placebo-controlled studies of BPN14770/zatolmilast to learn about the experimental drug’s safety and efficacy for males ages 12-45.
Study: Aging in Toolbox
Researchers around the country are conducting a study to better understand cognitive profiles in adults with intellectual disability. This study is an extension of the ongoing Toolbox Study, which is aimed to optimize cognitive assessment tools for children and young adults with intellectual disabilities.